Patient Characteristics
| Characteristic | Data |
| Median age (y) | 68 (IQR, 63–72) |
| Median PSA at PSMA PET (ng/mL) | 0.26 (IQR, 0.15–0.59) |
| Tumor stage (n) | |
| T2 | 58/260 (22.4%) |
| T3a | 111/260 (42.7%) |
| T3b | 41/260 (15.7%) |
| Missing | 50/260 (19.2%) |
| Positive surgical margins | 55/219 (25%) |
| Gleason score (n) | |
| 6−7 | 161/260 (58%) |
| 8−10 | 72/260 (42%) |
| Missing | 27/260 (10%) |
| Time to BCR from RP (mo) | 37.8 (IQR, 8.6–87.0) |
| Duration of follow-up since sRT (mo) | 38 (IQR, 31–43) |